ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

19.43
Delayed Data
As of Mar 21
 -0.33 / -1.67%
Today’s Change
12.24
Today|||52-Week Range
28.06
+22.05%
Year-to-Date
Biotech Stock Roundup: ACAD's Drug Approval, SGEN to be Acquired by PFE & More
Mar 16 / Zacks.com - Paid Partner Content
3 Nasdaq Stocks on Watch This Week
Mar 12 / MotleyFool.com - Paid Partner Content
Strength Seen in Acadia (ACAD): Can Its 5.0% Jump Turn into More Strength?
Mar 15 / Zacks.com - Paid Partner Content
BioNTech (BNTX) to Report Q4 Earnings: What's in the Cards?
Mar 10 / Zacks.com - Paid Partner Content
Acadia (ACAD) Gets FDA Approval for Daybue for Rett Syndrome
Mar 13 / Zacks.com - Paid Partner Content